Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 18 | 2023 | 16715 | 1.120 |
Why?
|
Encephalomyelitis, Eastern Equine | 1 | 2020 | 15 | 0.770 |
Why?
|
Relapsing Fever | 1 | 2020 | 19 | 0.760 |
Why?
|
Borrelia | 1 | 2020 | 67 | 0.740 |
Why?
|
AIDS Dementia Complex | 2 | 2019 | 154 | 0.720 |
Why?
|
RNA, Viral | 4 | 2021 | 2901 | 0.690 |
Why?
|
Cerebral Infarction | 2 | 2020 | 1011 | 0.640 |
Why?
|
Muscle Weakness | 2 | 2022 | 413 | 0.640 |
Why?
|
Crack Cocaine | 1 | 2017 | 32 | 0.610 |
Why?
|
Activins | 2 | 2009 | 208 | 0.580 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2020 | 652 | 0.570 |
Why?
|
Eukaryotic Initiation Factor-2B | 1 | 2016 | 9 | 0.570 |
Why?
|
Drug Resistance, Viral | 2 | 2018 | 820 | 0.530 |
Why?
|
Ovarian Diseases | 1 | 2016 | 139 | 0.500 |
Why?
|
Dementia | 3 | 2023 | 2518 | 0.490 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1622 | 0.490 |
Why?
|
Encephalitis | 3 | 2022 | 425 | 0.480 |
Why?
|
Renal Artery Obstruction | 1 | 2015 | 248 | 0.470 |
Why?
|
Cocaine-Related Disorders | 1 | 2017 | 460 | 0.460 |
Why?
|
Immune Evasion | 1 | 2017 | 360 | 0.460 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 238 | 0.450 |
Why?
|
Vasospasm, Intracranial | 1 | 2015 | 208 | 0.440 |
Why?
|
Apolipoprotein E4 | 1 | 2016 | 668 | 0.420 |
Why?
|
HIV-1 | 6 | 2023 | 6939 | 0.400 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1856 | 0.400 |
Why?
|
Autopsy | 4 | 2023 | 1020 | 0.390 |
Why?
|
HIV | 1 | 2018 | 1604 | 0.380 |
Why?
|
Meningitis | 2 | 2022 | 216 | 0.370 |
Why?
|
Depression | 2 | 2021 | 7759 | 0.350 |
Why?
|
Brain | 11 | 2023 | 26388 | 0.330 |
Why?
|
Skin Diseases | 1 | 2017 | 1066 | 0.320 |
Why?
|
Cognition Disorders | 1 | 2023 | 4043 | 0.320 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2017 | 2232 | 0.320 |
Why?
|
Metagenomics | 3 | 2021 | 428 | 0.320 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 452 | 0.300 |
Why?
|
Confusion | 2 | 2020 | 275 | 0.290 |
Why?
|
Cerebrospinal Fluid | 2 | 2020 | 535 | 0.290 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 697 | 0.280 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 475 | 0.280 |
Why?
|
Hypoxia, Brain | 1 | 2006 | 133 | 0.270 |
Why?
|
Central Nervous System | 6 | 2022 | 1357 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.260 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3046 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.260 |
Why?
|
Inflammation | 3 | 2021 | 10637 | 0.260 |
Why?
|
Alleles | 1 | 2016 | 6933 | 0.250 |
Why?
|
Lipids | 1 | 2016 | 3307 | 0.250 |
Why?
|
Depressive Disorder | 1 | 2017 | 3747 | 0.240 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2023 | 32 | 0.230 |
Why?
|
Anti-HIV Agents | 2 | 2018 | 4255 | 0.230 |
Why?
|
Humans | 55 | 2023 | 744366 | 0.230 |
Why?
|
Enzyme Activation | 1 | 2009 | 3702 | 0.220 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2023 | 140 | 0.220 |
Why?
|
CD4 Lymphocyte Count | 3 | 2018 | 2560 | 0.220 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1026 | 0.220 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2022 | 9 | 0.210 |
Why?
|
Viral Load | 4 | 2023 | 3300 | 0.210 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 1 | 2022 | 54 | 0.210 |
Why?
|
Cognition | 5 | 2023 | 6770 | 0.210 |
Why?
|
Middle Aged | 26 | 2023 | 213390 | 0.200 |
Why?
|
Brain Neoplasms | 1 | 2023 | 8861 | 0.200 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 39 | 0.200 |
Why?
|
Encephalitis, California | 1 | 2020 | 4 | 0.200 |
Why?
|
Encephalitis Virus, California | 1 | 2020 | 8 | 0.200 |
Why?
|
Metagenome | 2 | 2021 | 418 | 0.190 |
Why?
|
Herpesviridae Infections | 1 | 2022 | 277 | 0.190 |
Why?
|
Ischemic Attack, Transient | 1 | 2006 | 935 | 0.190 |
Why?
|
Dehydroepiandrosterone | 1 | 2021 | 252 | 0.180 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12961 | 0.180 |
Why?
|
Herpes Zoster | 1 | 2022 | 264 | 0.170 |
Why?
|
Paresis | 1 | 2021 | 179 | 0.170 |
Why?
|
Brain Injuries | 2 | 2022 | 2029 | 0.170 |
Why?
|
Speech Disorders | 1 | 2020 | 189 | 0.170 |
Why?
|
Exanthema | 1 | 2023 | 501 | 0.160 |
Why?
|
Neurocysticercosis | 1 | 2019 | 62 | 0.160 |
Why?
|
Frontotemporal Dementia | 1 | 2021 | 248 | 0.160 |
Why?
|
Policy | 1 | 2022 | 508 | 0.160 |
Why?
|
Male | 29 | 2023 | 350115 | 0.160 |
Why?
|
Encephalitis, Tick-Borne | 1 | 2018 | 34 | 0.150 |
Why?
|
Pituitary-Adrenal System | 1 | 2021 | 553 | 0.150 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2018 | 40 | 0.150 |
Why?
|
Viruses | 1 | 2021 | 375 | 0.150 |
Why?
|
Peripheral Nerves | 1 | 2021 | 466 | 0.150 |
Why?
|
Chemokines | 1 | 2021 | 970 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2022 | 743 | 0.150 |
Why?
|
Neurofilament Proteins | 1 | 2019 | 318 | 0.150 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 703 | 0.150 |
Why?
|
Frail Elderly | 1 | 2021 | 693 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 35425 | 0.140 |
Why?
|
Fatigue | 2 | 2022 | 1531 | 0.140 |
Why?
|
Female | 25 | 2023 | 380193 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.140 |
Why?
|
Pancytopenia | 1 | 2017 | 104 | 0.140 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 134 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1537 | 0.140 |
Why?
|
Adult | 17 | 2023 | 214052 | 0.140 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1019 | 0.130 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2021 | 1872 | 0.130 |
Why?
|
Retrospective Studies | 10 | 2023 | 77460 | 0.130 |
Why?
|
Anti-Retroviral Agents | 2 | 2022 | 1714 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15535 | 0.120 |
Why?
|
Sarcoma, Kaposi | 1 | 2017 | 370 | 0.120 |
Why?
|
Heart Rate | 2 | 2022 | 4092 | 0.120 |
Why?
|
Aged | 15 | 2022 | 163288 | 0.110 |
Why?
|
Hydrocortisone | 1 | 2021 | 1826 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1359 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4751 | 0.110 |
Why?
|
Antibodies, Viral | 2 | 2021 | 3177 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1888 | 0.110 |
Why?
|
Genotype | 2 | 2018 | 12952 | 0.110 |
Why?
|
Methotrexate | 1 | 2019 | 1728 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1410 | 0.110 |
Why?
|
Prospective Studies | 7 | 2021 | 53290 | 0.110 |
Why?
|
Brain Diseases | 1 | 2022 | 1563 | 0.110 |
Why?
|
Occupational Diseases | 1 | 2021 | 1469 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1170 | 0.110 |
Why?
|
Proteomics | 2 | 2022 | 3638 | 0.100 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 545 | 0.100 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2732 | 0.100 |
Why?
|
Homozygote | 1 | 2016 | 1787 | 0.100 |
Why?
|
Herpesvirus 3, Human | 2 | 2022 | 204 | 0.100 |
Why?
|
Brain Abscess | 1 | 2012 | 118 | 0.100 |
Why?
|
Neurons | 2 | 2009 | 9340 | 0.100 |
Why?
|
Frontal Lobe | 1 | 2017 | 1406 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.090 |
Why?
|
Injections, Intraventricular | 1 | 2009 | 231 | 0.090 |
Why?
|
Blood Pressure | 2 | 2022 | 8551 | 0.090 |
Why?
|
Risk Factors | 4 | 2023 | 72296 | 0.090 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1782 | 0.090 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 341 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4561 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6151 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3595 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2021 | 6994 | 0.080 |
Why?
|
Blood Gas Analysis | 1 | 2009 | 383 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2859 | 0.080 |
Why?
|
Neurology | 1 | 2016 | 763 | 0.080 |
Why?
|
United States | 6 | 2022 | 69872 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3219 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2566 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7323 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4153 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4925 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20130 | 0.070 |
Why?
|
Weight Loss | 1 | 2017 | 2625 | 0.070 |
Why?
|
Phenotype | 1 | 2023 | 16367 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 13991 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 21748 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.060 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.060 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 730 | 0.060 |
Why?
|
ROC Curve | 2 | 2021 | 3528 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8038 | 0.050 |
Why?
|
Proteome | 2 | 2022 | 1798 | 0.050 |
Why?
|
Orthostatic Intolerance | 1 | 2022 | 20 | 0.050 |
Why?
|
Dysgeusia | 1 | 2022 | 14 | 0.050 |
Why?
|
Proviruses | 1 | 2023 | 318 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9857 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6882 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2022 | 189 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4933 | 0.050 |
Why?
|
Microglia | 1 | 2009 | 1267 | 0.050 |
Why?
|
Young Adult | 2 | 2018 | 56429 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6598 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4257 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15078 | 0.050 |
Why?
|
Basal Ganglia | 1 | 2023 | 546 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6366 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13286 | 0.050 |
Why?
|
Limit of Detection | 1 | 2021 | 265 | 0.050 |
Why?
|
Hypertension | 1 | 2020 | 8479 | 0.050 |
Why?
|
Unconsciousness | 1 | 2022 | 263 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18373 | 0.040 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2022 | 257 | 0.040 |
Why?
|
Animals | 3 | 2023 | 168768 | 0.040 |
Why?
|
Intracranial Hemorrhages | 1 | 2023 | 855 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2022 | 672 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3680 | 0.040 |
Why?
|
Up-Regulation | 1 | 2006 | 4222 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 555 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.040 |
Why?
|
Cell Survival | 1 | 2006 | 5882 | 0.040 |
Why?
|
Electronic Health Records | 2 | 2023 | 4468 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2022 | 685 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14723 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3338 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2022 | 1322 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 40559 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39052 | 0.030 |
Why?
|
Memory Disorders | 1 | 2022 | 1186 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2022 | 1041 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1431 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 667 | 0.030 |
Why?
|
Headache | 1 | 2022 | 1226 | 0.030 |
Why?
|
Marijuana Abuse | 1 | 2017 | 403 | 0.030 |
Why?
|
Liver Diseases | 1 | 2021 | 1253 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1487 | 0.030 |
Why?
|
Rats | 1 | 2009 | 24252 | 0.030 |
Why?
|
Aging | 2 | 2021 | 8664 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2022 | 6171 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1364 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 2012 | 66 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15160 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 13035 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10259 | 0.020 |
Why?
|
Mice | 2 | 2009 | 81201 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 19233 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10252 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18034 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5709 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2022 | 1796 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8319 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6194 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1580 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3589 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 954 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2647 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
Time Factors | 1 | 2009 | 40075 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6234 | 0.020 |
Why?
|
Sleep | 1 | 2021 | 4622 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15221 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19905 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5749 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 13882 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6489 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29060 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29786 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 25039 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57776 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63107 | 0.010 |
Why?
|